Biotechnology Assets SA
MAD:BST
Income Statement
Earnings Waterfall
Biotechnology Assets SA
Income Statement
Biotechnology Assets SA
| Dec-2013 | Jun-2014 | Dec-2014 | Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
(0)
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
1
N/A
|
2
+117%
|
2
-1%
|
1
-69%
|
1
+126%
|
1
+4%
|
2
+76%
|
9
+292%
|
23
+149%
|
35
+51%
|
2
-94%
|
(17)
N/A
|
3
N/A
|
3
+14%
|
3
+8%
|
3
-4%
|
3
-12%
|
3
+22%
|
4
+13%
|
3
-15%
|
3
-18%
|
3
+4%
|
|
| Gross Profit | |||||||||||||||||||||||
| Cost of Revenue |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
(8)
|
(23)
|
(27)
|
(0)
|
12
|
(0)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
|
| Gross Profit |
1
N/A
|
2
+75%
|
3
+13%
|
1
-49%
|
2
+86%
|
2
-7%
|
3
+42%
|
1
-70%
|
0
-67%
|
8
+2 397%
|
2
-80%
|
(4)
N/A
|
2
N/A
|
1
-31%
|
1
+3%
|
2
+36%
|
2
-13%
|
2
+16%
|
2
+22%
|
2
-9%
|
2
-15%
|
2
+12%
|
|
| Operating Income | |||||||||||||||||||||||
| Operating Expenses |
(1)
|
(2)
|
(2)
|
(1)
|
(4)
|
(5)
|
(4)
|
(8)
|
(15)
|
(17)
|
(4)
|
3
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
1
|
1
|
(4)
|
(4)
|
(3)
|
|
| Selling, General & Administrative |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(7)
|
(14)
|
(16)
|
(2)
|
5
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
|
| Depreciation & Amortization |
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(4)
|
(3)
|
(2)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
|
| Other Operating Expenses |
(0)
|
(1)
|
(1)
|
(0)
|
(2)
|
(2)
|
(1)
|
1
|
1
|
2
|
3
|
1
|
1
|
0
|
0
|
0
|
0
|
5
|
5
|
0
|
(0)
|
0
|
|
| Operating Income |
0
N/A
|
1
+159%
|
0
-42%
|
0
-88%
|
(2)
N/A
|
(2)
-41%
|
(0)
+89%
|
(7)
-2 442%
|
(14)
-118%
|
(9)
+37%
|
(2)
+79%
|
(1)
+38%
|
(1)
+51%
|
(1)
-102%
|
(1)
-23%
|
(1)
+32%
|
(1)
-14%
|
3
N/A
|
3
+1%
|
(1)
N/A
|
(2)
-52%
|
(1)
+40%
|
|
| Pre-Tax Income | |||||||||||||||||||||||
| Interest Income Expense |
(0)
|
1
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(0)
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
0
N/A
|
1
+581%
|
1
-30%
|
(0)
N/A
|
(2)
-8 950%
|
(2)
-34%
|
(0)
+84%
|
(8)
-2 039%
|
(17)
-111%
|
(12)
+33%
|
(3)
+75%
|
(2)
+45%
|
(2)
+4%
|
(2)
-45%
|
(3)
-29%
|
(2)
+24%
|
(2)
+8%
|
2
N/A
|
2
-3%
|
(2)
N/A
|
(3)
-32%
|
(2)
+27%
|
|
| Net Income | |||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
(0)
|
1
|
1
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(1)
|
(1)
|
0
|
0
|
|
| Income from Continuing Operations |
0
|
1
|
1
|
(0)
|
(1)
|
(2)
|
(0)
|
(8)
|
(17)
|
(11)
|
(3)
|
(2)
|
(2)
|
(2)
|
(3)
|
(2)
|
(2)
|
3
|
2
|
(3)
|
(3)
|
(2)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
0
N/A
|
1
+168%
|
1
-6%
|
0
-98%
|
(1)
N/A
|
(2)
-33%
|
(0)
+95%
|
(8)
-11 443%
|
(17)
-110%
|
(11)
+33%
|
(10)
+12%
|
(17)
-72%
|
(9)
+50%
|
(1)
+91%
|
(3)
-291%
|
(2)
+23%
|
(2)
+16%
|
3
N/A
|
2
-37%
|
(3)
N/A
|
(3)
+4%
|
(2)
+29%
|
|
| EPS (Diluted) |
0.11
N/A
|
0.3
+173%
|
0.26
-13%
|
0
N/A
|
-0.22
N/A
|
-0.3
-36%
|
-0.01
+97%
|
-0.28
-2 700%
|
-0.43
-54%
|
-0.29
+33%
|
-0.25
+14%
|
-0.44
-76%
|
-0.21
+52%
|
-0.01
+95%
|
-0.07
-600%
|
-0.05
+29%
|
-0.04
+20%
|
0.04
N/A
|
0.03
-25%
|
-0.05
N/A
|
-0.05
N/A
|
-0.04
+20%
|
|